title: Calcium supplements and cardiovascular risk in the Women's Health Initiative: response to Bolland et al.
authors.forename: R L
authors.initials: RL
authors.lastname: Prentice
authors.forename: R D
authors.initials: RD
authors.lastname: Jackson
authors.forename: J E
authors.initials: JE
authors.lastname: Rossouw
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002119:Calcium Carbonate / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000627:therapeutic use*; D019587:Dietary Supplements / Q000009:adverse effects*; D005260:Female; D006801:Humans; D058866:Osteoporotic Fractures / Q000517:prevention & control*
chemical_list: D050071:Bone Density Conservation Agents; D002762:Cholecalciferol; D002119:Calcium Carbonate
references.citation: Osteoporos Int. 2013 Aug;24(8):2371-2
references.pmid: 23563934
references.citation: BMJ. 2011 Apr 19;342:d2040
references.pmid: 21505219
references.citation: BMJ. 2010 Jul 29;341:c3691
references.pmid: 20671013
references.citation: Osteoporos Int. 2013 Feb;24(2):567-80
references.pmid: 23208074
references.citation: Circulation. 2007 Feb 20;115(7):846-54
references.pmid: 17309935